Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Treatments for Lung Injury Induced by Limb Ischemia-Reperfusion in Elderly Patients
ChiCTR-IPR-17011252Phase 4Recruiting
- Sponsor
- Wenzhou People's Hospital
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in not applicable; "lung injury" is not a specific disease (4 arms), sponsored by Wenzhou People's Hospital. Primary endpoint: Interleukin levels. Started Apr 2017; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
not applicable; "lung injury" is not a specific disease
Beyond the preview
Go deeper on ChiCTR-IPR-17011252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011252.